X
Xiangmei Zhao
Researcher at Zhengzhou University
Publications - 6
Citations - 153
Xiangmei Zhao is an academic researcher from Zhengzhou University. The author has contributed to research in topics: Chemistry & Prospective cohort study. The author has an hindex of 4, co-authored 6 publications receiving 93 citations.
Papers
More filters
Journal ArticleDOI
Hypoglycemic and hypolipidemic effects of a polysaccharide from flower buds of Lonicera japonica in streptozotocin-induced diabetic rats.
TL;DR: The results suggested that LJP could be considered as an ingredient of functional foods for diabetes, and this is the first report about the hypoglycemic and hypolipidemic effects of the polysaccharides extracted from Lonicera japonica.
Journal ArticleDOI
Sunflower oil flavored by essential oil from Punica granatum cv. Heyinshiliu peels improved its oxidative stability and sensory properties
TL;DR: In this paper, Sunflower oil was produced by adding essential oil obtained from the peels of Punica granatum cv. Heyinshiliu (pomegranate, PPEO), which had significant antioxidant effects.
Journal ArticleDOI
Comparative investigation for hypoglycemic effects of polysaccharides from four substitutes of Lonicera japonica in Chinese medicine
TL;DR: The four polysaccharide fractions obtained from flower buds of the four substitutes of Lonicera japonica displayed notable hypoglycemic effects, similar to that of the poly Saccharide fraction from L. japonicas, so that they can be also considered as ingredients of functional foods for type-2 diabetes mellitus (T2DM).
Journal ArticleDOI
Lipid profile and prognosis in patients with coronary heart disease: a meta-analysis of prospective cohort studies.
TL;DR: In this paper, a meta-analysis based on prospective cohort studies aimed to evaluate the associations of lipid profiles with the risk of major adverse cardiovascular outcomes in patients with coronary heart disease (CHD).
Journal ArticleDOI
Improved Survival of Patients with ST-Segment Elevation Myocardial Infarction 3-6 Hours After Symptom Onset Is Associated with Inter-Hospital Transfer for Primary Percutaneous Coronary Intervention (PCI) at a Large Regional ST-Segment Elevation Myocardial Infarction (STEMI) Program vs. In-Hospital Thrombolysis in a Community Hospital.
TL;DR: In this paper, the authors compared the 30-day and 1-year survival of patients diagnosed with ST-segment elevation myocardial infarction (STEMI), whose symptom onset to in-hospital first medical contact (IHFMC) was 3-6 h, who received either inhospital thrombolysis (IHT) in the nearest county hospital or direct transfer to a larger hospital in Henan province, China for primary percutaneous coronary intervention (PPCI).